{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:40:16Z","timestamp":1792456816657,"version":"4.5.0"},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:00:00Z","timestamp":1792454400000},"content-version":"vor","delay-in-days":92,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-61960-2","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T08:35:02Z","timestamp":1784536502000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["An empirically refined workflow for generating patient-derived organoids from epithelial ovarian cancer"],"prefix":"10.1038","volume":"16","author":[{"given":"Long Hoang","family":"Ngo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Que Thanh Thanh","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanh Thi Tuyet","family":"Vo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi-Kyung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Kil","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"McClelland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9446-1059","authenticated-orcid":false,"given":"Eun-Ju","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,20]]},"reference":[{"key":"61960_CR1","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1038\/aps.2015.92","volume":"36","author":"XX Sun","year":"2015","unstructured":"Sun, X. X. & Yu, Q. Intra-tumor heterogeneity of cancer cells and its implications for cancer treatment. Acta Pharmacol. Sin. 36, 1219\u20131227. https:\/\/doi.org\/10.1038\/aps.2015.92 (2015).","journal-title":"Acta Pharmacol. Sin."},{"key":"61960_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2025.101520","volume":"12","author":"M Liu","year":"2025","unstructured":"Liu, M. & Yang, X. Patient-derived xenograft models: Current status, challenges, and innovations in cancer research. Genes Dis. 12, 101520. https:\/\/doi.org\/10.1016\/j.gendis.2025.101520 (2025).","journal-title":"Genes Dis."},{"key":"61960_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.crtox.2024.100197","volume":"7","author":"E Heinzelmann","year":"2024","unstructured":"Heinzelmann, E. et al. iPSC-derived and patient-derived organoids: Applications and challenges in scalability and reproducibility as pre-clinical models. Curr. Res. Toxicol. 7, 100197. https:\/\/doi.org\/10.1016\/j.crtox.2024.100197 (2024).","journal-title":"Curr. Res. Toxicol."},{"key":"61960_CR4","doi-asserted-by":"publisher","first-page":"C151","DOI":"10.1152\/ajpcell.00120.2020","volume":"319","author":"C Corro","year":"2020","unstructured":"Corro, C., Novellasdemunt, L. & Li, V. S. W. A brief history of organoids. Am. J. Physiol. Cell Physiol. 319, C151\u2013C165. https:\/\/doi.org\/10.1152\/ajpcell.00120.2020 (2020).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"61960_CR5","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/nature14966","volume":"525","author":"D Grun","year":"2015","unstructured":"Grun, D. et al. Single-cell messenger RNA sequencing reveals rare intestinal cell types. Nature 525, 251\u2013255. https:\/\/doi.org\/10.1038\/nature14966 (2015).","journal-title":"Nature"},{"key":"61960_CR6","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/s41556-020-0472-5","volume":"22","author":"B Artegiani","year":"2020","unstructured":"Artegiani, B. et al. Fast and efficient generation of knock-in human organoids using homology-independent CRISPR-Cas9 precision genome editing. Nat. Cell. Biol. 22, 321\u2013331. https:\/\/doi.org\/10.1038\/s41556-020-0472-5 (2020).","journal-title":"Nat. Cell. Biol."},{"key":"61960_CR7","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/nprot.2017.137","volume":"13","author":"A Fumagalli","year":"2018","unstructured":"Fumagalli, A. et al. A surgical orthotopic organoid transplantation approach in mice to visualize and study colorectal cancer progression. Nat. Protoc. 13, 235\u2013247. https:\/\/doi.org\/10.1038\/nprot.2017.137 (2018).","journal-title":"Nat. Protoc."},{"key":"61960_CR8","doi-asserted-by":"publisher","first-page":"1061388","DOI":"10.3389\/fimmu.2022.1061388","volume":"13","author":"J Yuan","year":"2022","unstructured":"Yuan, J., Li, X. & Yu, S. Cancer organoid co-culture model system: Novel approach to guide precision medicine. Front. Immunol. 13, 1061388. https:\/\/doi.org\/10.3389\/fimmu.2022.1061388 (2022).","journal-title":"Front. Immunol."},{"key":"61960_CR9","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.cell.2018.03.017","volume":"173","author":"SH Lee","year":"2018","unstructured":"Lee, S. H. et al. Tumor evolution and drug response in patient-derived organoid models of bladder cancer. Cell 173, 515-528 e517. https:\/\/doi.org\/10.1016\/j.cell.2018.03.017 (2018).","journal-title":"Cell"},{"key":"61960_CR10","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.cell.2019.11.036","volume":"180","author":"F Jacob","year":"2020","unstructured":"Jacob, F. et al. A patient-derived glioblastoma organoid model and biobank recapitulates inter- and intra-tumoral heterogeneity. Cell 180, 188-204 e122. https:\/\/doi.org\/10.1016\/j.cell.2019.11.036 (2020).","journal-title":"Cell"},{"key":"61960_CR11","doi-asserted-by":"publisher","first-page":"e100300","DOI":"10.15252\/embj.2018100300","volume":"38","author":"N Sachs","year":"2019","unstructured":"Sachs, N. et al. Long-term expanding human airway organoids for disease modeling. EMBO J 38, e100300. https:\/\/doi.org\/10.15252\/embj.2018100300 (2019).","journal-title":"EMBO J"},{"key":"61960_CR12","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.cell.2015.03.053","volume":"161","author":"M van de Wetering","year":"2015","unstructured":"van de Wetering, M. et al. Prospective derivation of a living organoid biobank of colorectal cancer patients. Cell 161, 933\u2013945. https:\/\/doi.org\/10.1016\/j.cell.2015.03.053 (2015).","journal-title":"Cell"},{"key":"61960_CR13","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1038\/s41556-019-0360-z","volume":"21","author":"M Boretto","year":"2019","unstructured":"Boretto, M. et al. Patient-derived organoids from endometrial disease capture clinical heterogeneity and are amenable to drug screening. Nat. Cell. Biol. 21, 1041\u20131051. https:\/\/doi.org\/10.1038\/s41556-019-0360-z (2019).","journal-title":"Nat. Cell. Biol."},{"key":"61960_CR14","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1158\/2159-8290.CD-18-1522","volume":"9","author":"E Driehuis","year":"2019","unstructured":"Driehuis, E. et al. Oral mucosal organoids as a potential platform for personalized cancer therapy. Cancer Discov. 9, 852\u2013871. https:\/\/doi.org\/10.1158\/2159-8290.CD-18-1522 (2019).","journal-title":"Cancer Discov."},{"key":"61960_CR15","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1038\/s41467-020-15155-6","volume":"11","author":"C Calandrini","year":"2020","unstructured":"Calandrini, C. et al. An organoid biobank for childhood kidney cancers that captures disease and tissue heterogeneity. Nat. Commun. 11, 1310. https:\/\/doi.org\/10.1038\/s41467-020-15155-6 (2020).","journal-title":"Nat. Commun."},{"key":"61960_CR16","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1038\/nm.4438","volume":"23","author":"L Broutier","year":"2017","unstructured":"Broutier, L. et al. Human primary liver cancer-derived organoid cultures for disease modeling and drug screening. Nat. Med. 23, 1424\u20131435. https:\/\/doi.org\/10.1038\/nm.4438 (2017).","journal-title":"Nat. Med."},{"key":"61960_CR17","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.cell.2017.11.010","volume":"172","author":"N Sachs","year":"2018","unstructured":"Sachs, N. et al. A living biobank of breast cancer organoids captures disease heterogeneity. Cell 172, 373-386 e310. https:\/\/doi.org\/10.1016\/j.cell.2017.11.010 (2018).","journal-title":"Cell"},{"key":"61960_CR18","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1158\/2159-8290.CD-18-0349","volume":"8","author":"H Tiriac","year":"2018","unstructured":"Tiriac, H. et al. Organoid profiling identifies common responders to chemotherapy in pancreatic cancer. Cancer Discov. 8, 1112\u20131129. https:\/\/doi.org\/10.1158\/2159-8290.CD-18-0349 (2018).","journal-title":"Cancer Discov."},{"key":"61960_CR19","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.cell.2014.08.016","volume":"159","author":"D Gao","year":"2014","unstructured":"Gao, D. et al. Organoid cultures derived from patients with advanced prostate cancer. Cell 159, 176\u2013187. https:\/\/doi.org\/10.1016\/j.cell.2014.08.016 (2014).","journal-title":"Cell"},{"key":"61960_CR20","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.stem.2018.09.016","volume":"23","author":"HHN Yan","year":"2018","unstructured":"Yan, H. H. N. et al. A comprehensive human gastric cancer organoid biobank captures tumor subtype heterogeneity and enables therapeutic screening. Cell Stem Cell 23, 882-897 e811. https:\/\/doi.org\/10.1016\/j.stem.2018.09.016 (2018).","journal-title":"Cell Stem Cell"},{"key":"61960_CR21","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1038\/s41591-019-0422-6","volume":"25","author":"O Kopper","year":"2019","unstructured":"Kopper, O. et al. An organoid platform for ovarian cancer captures intra- and interpatient heterogeneity. Nat. Med. 25, 838\u2013849. https:\/\/doi.org\/10.1038\/s41591-019-0422-6 (2019).","journal-title":"Nat. Med."},{"key":"61960_CR22","doi-asserted-by":"publisher","first-page":"14375","DOI":"10.1002\/cam4.5943","volume":"12","author":"C Zhou","year":"2023","unstructured":"Zhou, C. et al. Standardization of organoid culture in cancer research. Cancer Med 12, 14375\u201314386. https:\/\/doi.org\/10.1002\/cam4.5943 (2023).","journal-title":"Cancer Med"},{"key":"61960_CR23","doi-asserted-by":"publisher","first-page":"29","DOI":"10.3892\/mco.2021.2462","volume":"16","author":"Y Sisman","year":"2022","unstructured":"Sisman, Y., Schnack, T., Hogdall, E. & Hogdall, C. Organoids and epithelial ovarian cancer - a future tool for personalized treatment decisions? (Review). Mol. Clin. Oncol. 16, 29. https:\/\/doi.org\/10.3892\/mco.2021.2462 (2022).","journal-title":"Mol. Clin. Oncol."},{"key":"61960_CR24","doi-asserted-by":"publisher","DOI":"10.1177\/09636897241281869","author":"Y-H Chang","year":"2024","unstructured":"Chang, Y.-H., Wu, K.-C., Wang, K.-H. & Ding, D.-C. Ovarian cancer patient-derived organoids used as a model for replicating genetic characteristics and testing drug responsiveness: A preliminary study. Cell Transpl. https:\/\/doi.org\/10.1177\/09636897241281869 (2024).","journal-title":"Cell Transpl."},{"key":"61960_CR25","doi-asserted-by":"publisher","first-page":"198","DOI":"10.3892\/ol.2025.14944","volume":"29","author":"W Zhang","year":"2025","unstructured":"Zhang, W. et al. Prospects and challenges of ovarian cancer organoids in chemotherapy research (Review). Oncol. Lett. 29, 198. https:\/\/doi.org\/10.3892\/ol.2025.14944 (2025).","journal-title":"Oncol. Lett."},{"key":"61960_CR26","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2019104013","volume":"39","author":"K Hoffmann","year":"2020","unstructured":"Hoffmann, K. et al. Stable expansion of high-grade serous ovarian cancer organoids requires a low-Wnt environment. EMBO J. 39, e104013 (2020).","journal-title":"EMBO J."},{"key":"61960_CR27","doi-asserted-by":"publisher","first-page":"100429","DOI":"10.1016\/j.xpro.2021.100429","volume":"2","author":"N Maenhoudt","year":"2021","unstructured":"Maenhoudt, N. & Vankelecom, H. Protocol for establishing organoids from human ovarian cancer biopsies. STAR Protoc. 2, 100429. https:\/\/doi.org\/10.1016\/j.xpro.2021.100429 (2021).","journal-title":"STAR Protoc."},{"key":"61960_CR28","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1158\/2159-8290.CD-18-0474","volume":"8","author":"SJ Hill","year":"2018","unstructured":"Hill, S. J. et al. Prediction of DNA repair inhibitor response in short-term patient-derived ovarian cancer organoids. Cancer Discov. 8, 1404\u20131421. https:\/\/doi.org\/10.1158\/2159-8290.CD-18-0474 (2018).","journal-title":"Cancer Discov."},{"key":"61960_CR29","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/s43856-021-00019-x","volume":"1","author":"HF Berg","year":"2021","unstructured":"Berg, H. F. et al. Patient-derived organoids reflect the genetic profile of endometrial tumors and predict patient prognosis. Commun. Med. (Lond.) 1, 20. https:\/\/doi.org\/10.1038\/s43856-021-00019-x (2021).","journal-title":"Commun. Med. (Lond.)"},{"key":"61960_CR30","doi-asserted-by":"publisher","first-page":"2992","DOI":"10.1111\/cas.14119","volume":"110","author":"Y Maru","year":"2019","unstructured":"Maru, Y. et al. Establishment and characterization of patient-derived organoids from a young patient with cervical clear cell carcinoma. Cancer Sci. 110, 2992\u20133005. https:\/\/doi.org\/10.1111\/cas.14119 (2019).","journal-title":"Cancer Sci."},{"key":"61960_CR31","doi-asserted-by":"publisher","first-page":"12581","DOI":"10.1038\/s41598-020-69488-9","volume":"10","author":"Y Nanki","year":"2020","unstructured":"Nanki, Y. et al. Patient-derived ovarian cancer organoids capture the genomic profiles of primary tumours applicable for drug sensitivity and resistance testing. Sci. Rep. 10, 12581. https:\/\/doi.org\/10.1038\/s41598-020-69488-9 (2020).","journal-title":"Sci. Rep."},{"key":"61960_CR32","doi-asserted-by":"publisher","unstructured":"Sato, T. & Clevers, H. Primary mouse small intestinal epithelial cell cultures. 319\u2013328, https:\/\/doi.org\/10.1007\/978-1-62703-125-7_19 (2012).","DOI":"10.1007\/978-1-62703-125-7_19"},{"key":"61960_CR33","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3389\/fphar.2014.00061","volume":"5","author":"D Chiabrando","year":"2014","unstructured":"Chiabrando, D., Vinchi, F., Fiorito, V., Mercurio, S. & Tolosano, E. Heme in pathophysiology: A matter of scavenging, metabolism and trafficking across cell membranes. Front. Pharmacol. 5, 61. https:\/\/doi.org\/10.3389\/fphar.2014.00061 (2014).","journal-title":"Front. Pharmacol."},{"key":"61960_CR34","first-page":"648","volume":"64","author":"G Balla","year":"1991","unstructured":"Balla, G., Vercellotti, G. M., Muller-Eberhard, U., Eaton, J. & Jacob, H. S. Exposure of endothelial cells to free heme potentiates damage mediated by granulocytes and toxic oxygen species. Lab Invest. 64, 648\u2013655 (1991).","journal-title":"Lab Invest."},{"key":"61960_CR35","doi-asserted-by":"publisher","first-page":"1232528","DOI":"10.3389\/fcell.2023.1232528","volume":"11","author":"X Jiang","year":"2023","unstructured":"Jiang, X. et al. Organoids: opportunities and challenges of cancer therapy. Front. Cell Dev. Biol. 11, 1232528. https:\/\/doi.org\/10.3389\/fcell.2023.1232528 (2023).","journal-title":"Front. Cell Dev. Biol."},{"key":"61960_CR36","doi-asserted-by":"publisher","first-page":"15042","DOI":"10.1038\/srep15042","volume":"5","author":"S Gurung","year":"2015","unstructured":"Gurung, S., Werkmeister, J. A. & Gargett, C. E. Inhibition of transforming growth factor-beta receptor signaling promotes culture expansion of undifferentiated human endometrial mesenchymal stem\/stromal cells. Sci. Rep. 5, 15042. https:\/\/doi.org\/10.1038\/srep15042 (2015).","journal-title":"Sci. Rep."},{"key":"61960_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2022.878351","volume":"16","author":"F Regent","year":"2022","unstructured":"Regent, F. et al. Nicotinamide promotes formation of retinal organoids from human pluripotent stem cells via enhanced neural cell fate commitment. Front Cell Neurosci. 16, 878351. https:\/\/doi.org\/10.3389\/fncel.2022.878351 (2022).","journal-title":"Front Cell Neurosci."},{"key":"61960_CR38","doi-asserted-by":"publisher","first-page":"2536","DOI":"10.1089\/scd.2015.0018","volume":"24","author":"H Wang","year":"2015","unstructured":"Wang, H., Luo, X., Yao, L., Lehman, D. M. & Wang, P. Improvement of cell survival during human pluripotent stem cell definitive endoderm differentiation. Stem Cells Dev 24, 2536\u20132546. https:\/\/doi.org\/10.1089\/scd.2015.0018 (2015).","journal-title":"Stem Cells Dev"},{"key":"61960_CR39","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/j.bcp.2005.07.001","volume":"70","author":"SK Meurer","year":"2005","unstructured":"Meurer, S. K., Lahme, B., Tihaa, L., Weiskirchen, R. & Gressner, A. M. N-acetyl-L-cysteine suppresses TGF-beta signaling at distinct molecular steps: The biochemical and biological efficacy of a multifunctional, antifibrotic drug. Biochem. Pharmacol. 70, 1026\u20131034. https:\/\/doi.org\/10.1016\/j.bcp.2005.07.001 (2005).","journal-title":"Biochem. Pharmacol."},{"key":"61960_CR40","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1002\/ijc.28741","volume":"135","author":"LA Laviolette","year":"2014","unstructured":"Laviolette, L. A., Hodgkinson, K. M., Minhas, N., Perez-Iratxeta, C. & Vanderhyden, B. C. 17beta-estradiol upregulates GREB1 and accelerates ovarian tumor progression in vivo. Int. J. Cancer 135, 1072\u20131084. https:\/\/doi.org\/10.1002\/ijc.28741 (2014).","journal-title":"Int. J. Cancer"},{"key":"61960_CR41","doi-asserted-by":"publisher","first-page":"6027","DOI":"10.1073\/pnas.0401367101","volume":"101","author":"X Qi","year":"2004","unstructured":"Qi, X. et al. BMP4 supports self-renewal of embryonic stem cells by inhibiting mitogen-activated protein kinase pathways. Proc. Natl. Acad. Sci. U. S. A. 101, 6027\u20136032. https:\/\/doi.org\/10.1073\/pnas.0401367101 (2004).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"61960_CR42","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/ncb3312","volume":"18","author":"A Fatehullah","year":"2016","unstructured":"Fatehullah, A., Tan, S. H. & Barker, N. Organoids as an in vitro model of human development and disease. Nat. Cell Biol. 18, 246\u2013254. https:\/\/doi.org\/10.1038\/ncb3312 (2016).","journal-title":"Nat. Cell Biol."},{"key":"61960_CR43","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/ncb3337","volume":"18","author":"L Planas-Paz","year":"2016","unstructured":"Planas-Paz, L. et al. The RSPO\u2013LGR4\/5\u2013ZNRF3\/RNF43 module controls liver zonation and size. Nat. Cell Biol. 18, 467\u2013479. https:\/\/doi.org\/10.1038\/ncb3337 (2016).","journal-title":"Nat. Cell Biol."},{"key":"61960_CR44","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.stem.2018.11.016","volume":"23","author":"M Fujii","year":"2018","unstructured":"Fujii, M. et al. Human intestinal organoids maintain self-renewal capacity and cellular diversity in niche-inspired culture condition. Cell Stem Cell 23, 787-793 e786. https:\/\/doi.org\/10.1016\/j.stem.2018.11.016 (2018).","journal-title":"Cell Stem Cell"},{"key":"61960_CR45","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1038\/342440a0","volume":"342","author":"T Nakamura","year":"1989","unstructured":"Nakamura, T. et al. Molecular cloning and expression of human hepatocyte growth factor. Nature 342, 440\u2013443. https:\/\/doi.org\/10.1038\/342440a0 (1989).","journal-title":"Nature"},{"key":"61960_CR46","doi-asserted-by":"publisher","first-page":"13207","DOI":"10.1038\/ncomms13207","volume":"7","author":"T Jarde","year":"2016","unstructured":"Jarde, T. et al. Wnt and Neuregulin1\/ErbB signalling extends 3D culture of hormone responsive mammary organoids. Nat. Commun. 7, 13207. https:\/\/doi.org\/10.1038\/ncomms13207 (2016).","journal-title":"Nat. Commun."},{"key":"61960_CR47","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/1476-4598-5-62","volume":"5","author":"K Rask","year":"2006","unstructured":"Rask, K., Zhu, Y., Wang, W., Hedin, L. & Sundfeldt, K. Ovarian epithelial cancer: a role for PGE2-synthesis and signalling in malignant transformation and progression. Mol. Cancer 5, 62. https:\/\/doi.org\/10.1186\/1476-4598-5-62 (2006).","journal-title":"Mol. Cancer"},{"key":"61960_CR48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0012148","volume":"5","author":"N Emre","year":"2010","unstructured":"Emre, N. et al. The ROCK inhibitor Y-27632 improves recovery of human embryonic stem cells after fluorescence-activated cell sorting with multiple cell surface markers. PLoS ONE 5, e12148. https:\/\/doi.org\/10.1371\/journal.pone.0012148 (2010).","journal-title":"PLoS ONE"},{"key":"61960_CR49","doi-asserted-by":"publisher","first-page":"17365","DOI":"10.1038\/s41598-019-53907-7","volume":"9","author":"J Otte","year":"2019","unstructured":"Otte, J. et al. FGF signalling in the self-renewal of colon cancer organoids. Sci. Rep. 9, 17365. https:\/\/doi.org\/10.1038\/s41598-019-53907-7 (2019).","journal-title":"Sci. Rep."},{"key":"61960_CR50","doi-asserted-by":"publisher","first-page":"574","DOI":"10.3389\/fcell.2020.00574","volume":"8","author":"A Rabata","year":"2020","unstructured":"Rabata, A., Fedr, R., Soucek, K., Hampl, A. & Koledova, Z. 3D cell culture models demonstrate a role for FGF and WNT signaling in regulation of lung epithelial cell fate and morphogenesis. Front. Cell Dev. Biol. 8, 574. https:\/\/doi.org\/10.3389\/fcell.2020.00574 (2020).","journal-title":"Front. Cell Dev. Biol."},{"key":"61960_CR51","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/nature14863","volume":"524","author":"B Wang","year":"2015","unstructured":"Wang, B., Zhao, L., Fish, M., Logan, C. Y. & Nusse, R. Self-renewing diploid Axin2(+) cells fuel homeostatic renewal of the liver. Nature 524, 180\u2013185. https:\/\/doi.org\/10.1038\/nature14863 (2015).","journal-title":"Nature"},{"key":"61960_CR52","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1002\/9780470942390.mo130179","volume":"3","author":"MM Mahe","year":"2013","unstructured":"Mahe, M. M. et al. Establishment of gastrointestinal epithelial organoids. Curr. Protoc. Mouse Biol. 3, 217\u2013240. https:\/\/doi.org\/10.1002\/9780470942390.mo130179 (2013).","journal-title":"Curr. Protoc. Mouse Biol."},{"key":"61960_CR53","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.stem.2020.06.021","volume":"27","author":"T Jarde","year":"2020","unstructured":"Jarde, T. et al. Mesenchymal niche-derived neuregulin-1 drives intestinal stem cell proliferation and regeneration of damaged epithelium. Cell Stem Cell 27, 646-662 e647. https:\/\/doi.org\/10.1016\/j.stem.2020.06.021 (2020).","journal-title":"Cell Stem Cell"},{"key":"61960_CR54","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.stemcr.2020.03.004","volume":"14","author":"N Maenhoudt","year":"2020","unstructured":"Maenhoudt, N. et al. Developing organoids from ovarian cancer as experimental and preclinical models. Stem Cell Reports 14, 717\u2013729. https:\/\/doi.org\/10.1016\/j.stemcr.2020.03.004 (2020).","journal-title":"Stem Cell Reports"},{"key":"61960_CR55","doi-asserted-by":"publisher","first-page":"10412","DOI":"10.1038\/s41598-023-35657-9","volume":"13","author":"JY Co","year":"2023","unstructured":"Co, J. Y., Klein, J. A., Kang, S. & Homan, K. A. Suspended hydrogel culture as a method to scale up intestinal organoids. Sci. Rep. 13, 10412. https:\/\/doi.org\/10.1038\/s41598-023-35657-9 (2023).","journal-title":"Sci. Rep."},{"key":"61960_CR56","doi-asserted-by":"publisher","first-page":"2662","DOI":"10.1080\/15384101.2020.1817666","volume":"19","author":"Y Han","year":"2020","unstructured":"Han, Y. et al. Wilms\u2019 tumor 1 (WT1) promotes ovarian cancer progression by regulating E-cadherin and ERK1\/2 signaling. Cell Cycle 19, 2662\u20132675. https:\/\/doi.org\/10.1080\/15384101.2020.1817666 (2020).","journal-title":"Cell Cycle"},{"key":"61960_CR57","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1038\/s41416-018-0191-x","volume":"119","author":"JH Carter","year":"2018","unstructured":"Carter, J. H. et al. Transcription factors WT1 and p53 combined: a prognostic biomarker in ovarian cancer. Br. J. Cancer 119, 462\u2013470. https:\/\/doi.org\/10.1038\/s41416-018-0191-x (2018).","journal-title":"Br. J. Cancer"},{"key":"61960_CR58","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.3390\/cancers12061607","volume":"12","author":"M McMullen","year":"2020","unstructured":"McMullen, M., Karakasis, K., Madariaga, A. & Oza, A. M. Overcoming platinum and PARP-inhibitor resistance in ovarian cancer. Cancers (Basel) 12, 1607. https:\/\/doi.org\/10.3390\/cancers12061607 (2020).","journal-title":"Cancers (Basel)"},{"key":"61960_CR59","doi-asserted-by":"publisher","first-page":"448","DOI":"10.3390\/cancers15020448","volume":"15","author":"M Ovejero-Sanchez","year":"2023","unstructured":"Ovejero-Sanchez, M., Gonzalez-Sarmiento, R. & Herrero, A. B. DNA damage response alterations in ovarian cancer: From molecular mechanisms to therapeutic opportunities. Cancers (Basel) 15, 448. https:\/\/doi.org\/10.3390\/cancers15020448 (2023).","journal-title":"Cancers (Basel)"},{"key":"61960_CR60","doi-asserted-by":"publisher","first-page":"573","DOI":"10.20517\/cdr.2021.05","volume":"4","author":"N Rinne","year":"2021","unstructured":"Rinne, N. et al. Targeting the PI3K\/AKT\/mTOR pathway in epithelial ovarian cancer, therapeutic treatment options for platinum-resistant ovarian cancer. Cancer Drug Resist. 4, 573\u2013595. https:\/\/doi.org\/10.20517\/cdr.2021.05 (2021).","journal-title":"Cancer Drug Resist."},{"key":"61960_CR61","doi-asserted-by":"publisher","first-page":"e70295","DOI":"10.1002\/mco2.70295","volume":"6","author":"M Jiang","year":"2025","unstructured":"Jiang, M. et al. PI3K\/AKT\/mTOR Axis in Cancer: From Pathogenesis to Treatment. MedComm (2020) 6, e70295. https:\/\/doi.org\/10.1002\/mco2.70295 (2025).","journal-title":"MedComm (2020)"},{"key":"61960_CR62","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1038\/s41416-022-02084-y","volume":"128","author":"Y Wang","year":"2023","unstructured":"Wang, Y. et al. Evolving landscape of PD-L2: Bring new light to checkpoint immunotherapy. Br. J. Cancer 128, 1196\u20131207. https:\/\/doi.org\/10.1038\/s41416-022-02084-y (2023).","journal-title":"Br. J. Cancer"},{"key":"61960_CR63","doi-asserted-by":"publisher","first-page":"1359532","DOI":"10.3389\/fimmu.2024.1359532","volume":"15","author":"Y Yang","year":"2024","unstructured":"Yang, Y., Yan, X., Bai, X., Yang, J. & Song, J. Programmed cell death-ligand 2: new insights in cancer. Front. Immunol. 15, 1359532. https:\/\/doi.org\/10.3389\/fimmu.2024.1359532 (2024).","journal-title":"Front. Immunol."},{"key":"61960_CR64","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/nrc3239","volume":"12","author":"DM Pardoll","year":"2012","unstructured":"Pardoll, D. M. The blockade of immune checkpoints in cancer immunotherapy. Nat. Rev. Cancer 12, 252\u2013264. https:\/\/doi.org\/10.1038\/nrc3239 (2012).","journal-title":"Nat. Rev. Cancer"},{"key":"61960_CR65","doi-asserted-by":"publisher","first-page":"1352053","DOI":"10.3389\/fonc.2024.1352053","volume":"14","author":"A Jlassi","year":"2024","unstructured":"Jlassi, A. et al. VISTA\/CTLA4\/PD1 coexpression on tumor cells confers a favorable immune microenvironment and better prognosis in high-grade serous ovarian carcinoma. Front. Oncol. 14, 1352053. https:\/\/doi.org\/10.3389\/fonc.2024.1352053 (2024).","journal-title":"Front. Oncol."},{"key":"61960_CR66","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s43586-022-00174-y","volume":"2","author":"Z Zhao","year":"2022","unstructured":"Zhao, Z. et al. Organoids. Nat. Rev. Methods Primers 2, 94. https:\/\/doi.org\/10.1038\/s43586-022-00174-y (2022).","journal-title":"Nat. Rev. Methods Primers"},{"key":"61960_CR67","doi-asserted-by":"publisher","first-page":"729","DOI":"10.3390\/cells13090729","volume":"13","author":"HY Kim","year":"2024","unstructured":"Kim, H. Y. et al. Patient-derived organoids recapitulate pathological intrinsic and phenotypic features of fibrous dysplasia. Cells 13, 729. https:\/\/doi.org\/10.3390\/cells13090729 (2024).","journal-title":"Cells"},{"key":"61960_CR68","doi-asserted-by":"publisher","DOI":"10.3791\/65040","author":"M Bannier-Helaouet","year":"2023","unstructured":"Bannier-Helaouet, M., Geurts, M. H., Korving, J., Begthel, H. & Clevers, H. Establishment, maintenance, differentiation, genetic manipulation, and transplantation of mouse and human lacrimal gland organoids. J Vis Exp https:\/\/doi.org\/10.3791\/65040 (2023).","journal-title":"J Vis Exp"},{"key":"61960_CR69","doi-asserted-by":"publisher","DOI":"10.3791\/61541","author":"B Konda","year":"2020","unstructured":"Konda, B. et al. Isolation and enrichment of human lung epithelial progenitor cells for organoid culture. J. Vis. Exp. https:\/\/doi.org\/10.3791\/61541 (2020).","journal-title":"J. Vis. Exp."},{"key":"61960_CR70","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1016\/j.devcel.2023.04.012","volume":"58","author":"W Senkowski","year":"2023","unstructured":"Senkowski, W. et al. A platform for efficient establishment and drug-response profiling of high-grade serous ovarian cancer organoids. Dev. Cell 58, 1106-1121 e1107. https:\/\/doi.org\/10.1016\/j.devcel.2023.04.012 (2023).","journal-title":"Dev. Cell"},{"key":"61960_CR71","doi-asserted-by":"publisher","first-page":"6469","DOI":"10.1038\/s41388-021-02059-y","volume":"40","author":"EJ Ter Steege","year":"2021","unstructured":"Ter Steege, E. J. & Bakker, E. R. M. The role of R-spondin proteins in cancer biology. Oncogene 40, 6469\u20136478. https:\/\/doi.org\/10.1038\/s41388-021-02059-y (2021).","journal-title":"Oncogene"},{"key":"61960_CR72","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1038\/s41551-020-0565-2","volume":"4","author":"N Brandenberg","year":"2020","unstructured":"Brandenberg, N. et al. High-throughput automated organoid culture via stem-cell aggregation in microcavity arrays. Nat. Biomed. Eng. 4, 863\u2013874. https:\/\/doi.org\/10.1038\/s41551-020-0565-2 (2020).","journal-title":"Nat. Biomed. Eng."},{"key":"61960_CR73","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1002\/bit.260390408","volume":"39","author":"SS Ozturk","year":"1992","unstructured":"Ozturk, S. S., Riley, M. R. & Palsson, B. O. Effects of ammonia and lactate on hybridoma growth, metabolism, and antibody production. Biotechnol. Bioeng. 39, 418\u2013431. https:\/\/doi.org\/10.1002\/bit.260390408 (1992).","journal-title":"Biotechnol. Bioeng."},{"key":"61960_CR74","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nrm.2017.125","volume":"19","author":"G van Niel","year":"2018","unstructured":"van Niel, G., D\u2019Angelo, G. & Raposo, G. Shedding light on the cell biology of extracellular vesicles. Nat. Rev. Mol. Cell Biol. 19, 213\u2013228. https:\/\/doi.org\/10.1038\/nrm.2017.125 (2018).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"61960_CR75","doi-asserted-by":"publisher","first-page":"2471","DOI":"10.1038\/nprot.2013.153","volume":"8","author":"H Miyoshi","year":"2013","unstructured":"Miyoshi, H. & Stappenbeck, T. S. In vitro expansion and genetic modification of gastrointestinal stem cells in spheroid culture. Nat Protoc 8, 2471\u20132482. https:\/\/doi.org\/10.1038\/nprot.2013.153 (2013).","journal-title":"Nat Protoc"},{"key":"61960_CR76","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1016\/j.cell.2018.11.021","volume":"175","author":"JT Neal","year":"2018","unstructured":"Neal, J. T. et al. Organoid modeling of the tumor immune microenvironment. Cell 175, 1972-1988 e1916. https:\/\/doi.org\/10.1016\/j.cell.2018.11.021 (2018).","journal-title":"Cell"},{"key":"61960_CR77","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1016\/j.cell.2018.07.009","volume":"174","author":"KK Dijkstra","year":"2018","unstructured":"Dijkstra, K. K. et al. Generation of tumor-reactive t cells by co-culture of peripheral blood lymphocytes and tumor organoids. Cell 174, 1586-1598 e1512. https:\/\/doi.org\/10.1016\/j.cell.2018.07.009 (2018).","journal-title":"Cell"},{"key":"61960_CR78","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/978-3-319-67577-0_4","volume":"1036","author":"T Frankel","year":"2017","unstructured":"Frankel, T., Lanfranca, M. P. & Zou, W. The role of tumor microenvironment in cancer immunotherapy. Adv. Exp. Med. Biol. 1036, 51\u201364. https:\/\/doi.org\/10.1007\/978-3-319-67577-0_4 (2017).","journal-title":"Adv. Exp. Med. Biol."},{"key":"61960_CR79","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1038\/s41416-019-0616-1","volume":"121","author":"G Scognamiglio","year":"2019","unstructured":"Scognamiglio, G. et al. Patient-derived organoids as a potential model to predict response to PD-1\/PD-L1 checkpoint inhibitors. Br. J. Cancer 121, 979\u2013982. https:\/\/doi.org\/10.1038\/s41416-019-0616-1 (2019).","journal-title":"Br. J. Cancer"},{"key":"61960_CR80","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-006290","volume":"11","author":"L Magre","year":"2023","unstructured":"Magre, L. et al. Emerging organoid-immune co-culture models for cancer research: From oncoimmunology to personalized immunotherapies. J. Immunother. Cancer 11, e006290. https:\/\/doi.org\/10.1136\/jitc-2022-006290 (2023).","journal-title":"J. Immunother. Cancer"},{"key":"61960_CR81","doi-asserted-by":"publisher","first-page":"3750","DOI":"10.1038\/s41598-021-83276-z","volume":"11","author":"SK Parvathareddy","year":"2021","unstructured":"Parvathareddy, S. K. et al. Differential expression of PD-L1 between primary and metastatic epithelial ovarian cancer and its clinico-pathological correlation. Sci Rep 11, 3750. https:\/\/doi.org\/10.1038\/s41598-021-83276-z (2021).","journal-title":"Sci Rep"},{"key":"61960_CR82","unstructured":"66Illumina. DRAGEN secondary analysis (Version 07.021.624.3.10.9). (2024)."},{"key":"61960_CR83","doi-asserted-by":"publisher","first-page":"D1331","DOI":"10.1093\/nar\/gkaf1250","volume":"54","author":"J Casper","year":"2026","unstructured":"Casper, J. et al. The UCSC Genome Browser database: 2026 update. Nucleic Acids Res. 54, D1331\u2013D1335. https:\/\/doi.org\/10.1093\/nar\/gkaf1250 (2026).","journal-title":"Nucleic Acids Res."},{"key":"61960_CR84","unstructured":"Andrews, S. FastQC: a quality control tool for high throughput sequence data. https:\/\/www.bioinformatics.babraham.ac.uk\/projects\/fastqc\/ (2010)."},{"key":"61960_CR85","doi-asserted-by":"publisher","unstructured":"Li, H. Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM. arXiv, https:\/\/doi.org\/10.48550\/arXiv.1303.3997 (2013).","DOI":"10.48550\/arXiv.1303.3997"},{"key":"61960_CR86","unstructured":"Institute, B. Picard toolkit. Broad Institute, GitHub repository (2019)."},{"key":"61960_CR87","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1038\/s41586-020-2287-8","volume":"581","author":"RL Collins","year":"2020","unstructured":"Collins, R. L. et al. A structural variation reference for medical and population genetics. Nature 581, 444\u2013451. https:\/\/doi.org\/10.1038\/s41586-020-2287-8 (2020).","journal-title":"Nature"},{"key":"61960_CR88","doi-asserted-by":"publisher","first-page":"80","DOI":"10.4161\/fly.19695","volume":"6","author":"P Cingolani","year":"2012","unstructured":"Cingolani, P. et al. A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3. Fly (Austin) 6, 80\u201392. https:\/\/doi.org\/10.4161\/fly.19695 (2012).","journal-title":"Fly (Austin)"},{"key":"61960_CR89","doi-asserted-by":"publisher","first-page":"btae08","DOI":"10.1093\/bioinformatics\/btae038","volume":"40","author":"G Genovese","year":"2024","unstructured":"Genovese, G. et al. BCFtools\/liftover: An accurate and comprehensive tool to convert genetic variants across genome assemblies. Bioinformatics 40, btae08. https:\/\/doi.org\/10.1093\/bioinformatics\/btae038 (2024).","journal-title":"Bioinformatics"},{"key":"61960_CR90","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1109\/MCSE.2007.55","volume":"9","author":"JD Hunter","year":"2007","unstructured":"Hunter, J. D. Matplotlib: A 2D graphics environment. Comput. Sci. Eng. 9, 90\u201395. https:\/\/doi.org\/10.1109\/MCSE.2007.55 (2007).","journal-title":"Comput. Sci. Eng."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-61960-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-61960-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-61960-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:06:22Z","timestamp":1792454782000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-61960-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,20]]},"references-count":90,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["61960"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-61960-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,20]]},"assertion":[{"value":"22 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Informed consent was obtained before the collection of any patient data or tissue samples. This study was approved by the Research Ethics Board of Chung-Ang University (approval number: 2109-004-476).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The data used in this study were obtained from individuals who provided informed consent for the use of their deidentified information solely for research purposes.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"32976"}}